InvestorsHub Logo
icon url

freethemice

01/04/13 6:01 PM

#106265 RE: spacey #106264

If Roche/Genentech were to be the partner these facilities would provide more than enough capacity.

Vacaville, California
Located on 100 acres in Solano County - just 50 miles northeast of San Francisco - the Vacaville site was acquired in 1994.
Today, the Vacaville site is one of the world's largest biotechnology manufacturing plants for the large-scale production of pharmaceutical proteins from mammalian cells. There are more than 427,000 square feet of space devoted to manufacturing, maintenance, laboratories, office space and warehousing.
http://www.gene.com/contact-us/visit-us/vacaville

Oceanside, California
Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego.
Today, the campus spans 60 acres and includes a multi-product, biotech manufacturing and clinical operations complex with six buildings totaling 500,000 square feet. Upon receiving U.S. Food and Drug Administration licensure in 2007, the Oceanside facility added 90,000 liters of capacity that are now approved for the production of Rituxan and Avastin bulk drug substance.
http://www.gene.com/contact-us/visit-us/oceanside
icon url

Protector

01/04/13 8:23 PM

#106274 RE: spacey #106264

Which is not a bad thing because I think it is better Peregrine concentrates on developing the platforms (oncology, viral, digital imaging, and other conditions - interferon, antibiotics alternative, animal medicine, etc whatever would be new fields where Bavi can do the job or help doing the job), rather then become a production facility for large market demands.

Leave that to the BP with their facilities or to set-up facilities world wide, their distribution nets, their marketing channels, etc.